Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants

Archives of Dermatology

Volumn 137, Issue 4, 2001, Pages 459-463

  Otley, Clark C ^a   Coldiron, Brett M ^d   Stasko, Thomas ^b   Goldman, Glenn D ^c  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SKIN CANCER; VERRUCA VULGARIS;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PANCREAS TRANSPLANTATION; SKIN NEOPLASMS; TIME FACTORS;

EID: 0035051159     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Occurrence of cancers in immunosuppressed organ transplant recipients
2. The risk of skin cancer in renal transplant recipients in Queensland, Australia: A follow-up study
3. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
4. High incidence and clinical course of aggressive skin cancer in heart transplant patients: A single-center study
5. Weaning of immunosuppression in long-term liver transplant recipients
6. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens
7. Remission of transplanted melanoma: Clinical course and turnout cell characterisation
8. Prevention of skin cancer in xeroderma pigmentation with the use of oral isotretinoin
9. Kidney failure or cancer: Should immunosuppression be continued in a transplant patient with malignant melanoma?